
|Articles|December 5, 2012
Ranbaxy launches isotretinoin product in U.S.
Ranbaxy is launching its isotretinoin product for the treatment of acne, Absorica, in the United States.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
KT-621 Produces 98% STAT6 Degradation in AD Patients
2
Transparency Gaps in Prior Authorization Denials and Their Impact on Dermatologic Care
3
AI at the Bedside: How Automated Solutions are Transforming Vitiligo Management
4
Celebrating a Year of Growth and Research
5



















